China Health Group Limited (trading in Hong Kong as CHG HS Limited) filed its Monthly Return for Equity Issuer with Hong Kong Exchanges and Clearing on 3 September 2026, confirming that no changes occurred in its share capital during August 2026.

The company’s authorised share capital remained at 100.00 billion ordinary shares with a par value of HKD0.10, equivalent to HKD10.00 billion. Authorised preference shares were unchanged at 15,000 redeemable convertible cumulative preference shares with a par value of USD0.01, equal to approximately HKD1,164.

Issued share capital stood at 1.39 billion ordinary shares, with zero treasury shares recorded both at the start and end of the month. Consequently, total issued shares and the company’s equity base were flat month-on-month.

China Health Group confirmed compliance with the Main Board’s minimum public-float requirement of 25%, indicating that sufficient shares remain in public hands.

The firm’s 2012 Share Option Scheme continues to carry 20.84 million outstanding options, representing a potential dilution of about 1.5% of the current issued share base if fully exercised. No options were exercised, lapsed, or cancelled in August, and no new options were granted.

The filing reports no outstanding warrants, convertible securities, or other share-issuance arrangements, and there were no repurchases or transfers of treasury shares.

Overall, the August return highlights a period of capital stability for China Health Group, with steady authorised and issued share figures, full public-float compliance, and no equity dilution events during the month.